LORATADINE TABLETS

The Defense Logistics Agency awarded a delivery order under basic contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of 6,000 packages of loratadine tablets, identified by NSN 6505013770448 and purchase request 7017496461, at a total price of $120.06. The award was issued on July 14, 2026, with delivery required by July 29, 2026, to the designated location at Fort Bragg, North Carolina, under FOB Destination terms, meaning the contractor assumes all transportation costs and risks until delivery. Payment is handled through the Defense Finance and Accounting Service in Columbus, Ohio, with invoices to be submitted electronically in accordance with DFARS 252.232-7003, typically via the Wide Area Workflow system. The contract specifies a strict zero percent quantity variance, requiring exact adherence to the ordered amount, and mandates traceable shipping methods with exclusion of parcel post. Inspection and acceptance occur at the destination by government representatives, and the product must conform to the contract requirements as defined under the referenced basic contract. The contracting officer is Lisa Quinn, reachable via email, with Shairy M. Cartagena serving as the local point of contact for administrative matters. The National Industrial Classification System code for this transaction is 424210, classifying it under Pharmaceutical and Biological Product Merchant Wholesalers. While the delivery order references the terms of its base indefinite-delivery/indefinite-quantity contract, specific FAR or DFARS clauses, packaging standards, inspection criteria, socioeconomic certifications, or representations were not included in the available documentation. Applicable accounting data is denoted by the BX code 97X4930 5CBX 001 2620 S33189, and no options, modifications, or additional line items are present.